Skip to content

Member

Christophe CLERGEAU

S&D · France

Group
S&D
Country
France
Roll-call participation
81.8 %ⓘ of 620 roll calls in office · chamber median 90.6 % · whole term, final votes
With majority line
93.3 %ⓘ of 507 votes where the group had a line · S&D median 97.1 %
More facts (5)
National party
PS Parti socialiste
In office
Since 16 Jul 2024
Against clear line
29 of 500 votesⓘ
Committees
DEVE (substitute), ENVI, ITRE (substitute), SANT
Member id
245018
More

Record

The member’s figures against the median of their group and of the chamber. Each vote counts the member in the group they belonged to that day.

Roll-call participation ⓘ

81.8 %

507 of 620 final votes while in office

S&D median: 89.5 % (−7.7 pts)

Chamber median: 90.6 %

With majority line ⓘ

93.3 %

473 of 507 votes where their group had a line

S&D median: 97.1 % (−3.8 pts)

Against clear line ⓘ

5.8 %

29 of 500 votes where their group had a clear line

12 opposite (for ↔ against), 16 abstained against the line, 1 voted for or against when the line was to abstain

Abstention ⓘ

4.1 %

21 of 507 votes cast

Participation 81.8 % — S&D median 89.5 %, 137 members.ⓘ
Data as a table
Participation among the 137 members of the S&D with enough votes.
FigureParticipation
Christophe CLERGEAU81.8 %
S&D median89.5 %
Lowest in the group48.1 %
Highest in the group99.8 %
Members137
With majority line 93.3 % — S&D median 97.1 %, 137 members.ⓘ
Data as a table
With majority line among the 137 members of the S&D with enough votes.
FigureWith majority line
Christophe CLERGEAU93.3 %
S&D median97.1 %
Lowest in the group86.7 %
Highest in the group99.8 %
Members137
  • Whole term, 620 final votes; 620 of 794 decisions had a final vote recorded by name. The dots are the other members of S&D; no ranks.
  • “No vote recorded” is not the same as absent: leave, illness and chairing the sitting look the same.
  • A group’s line is inferred from its members’ votes — Parliament publishes no whip.

Votes, 620

Export

Every final roll-call vote of the term with the member’s position, newest first.

Result: for–against–abstained. Majority line: how most of the member’s group voted that day (“Tie” when no position won). ≠ group marks a vote otherwise than a clear line (at least two thirds, with at least 10 members voting) of their group.
DateDecisionResultPositionMajority line
11 Mar 2026Recommendation on enhanced EU-Canada cooperation in the current geopolitical context, including the threats to Canada’s economic stability and sovereignty Adopted 482 for, 108 against, 42 abstainedPosition: For Majority line: For
11 Mar 2026Tackling barriers to the single market for defence Adopted 393 for, 169 against, 67 abstainedPosition: For Majority line: For
11 Mar 2026Flagship European defence projects of common interest Adopted 448 for, 122 against, 38 abstainedPosition: For Majority line: For
10 Mar 2026Harmonising certain aspects of insolvency law Passed 498 for, 90 against, 28 abstainedPosition: For Majority line: For
10 Mar 2026Establishing an EU talent pool Passed 414 for, 182 against, 21 abstainedPosition: For Majority line: For
10 Mar 2026Increased efficiency of the External Action Guarantee Passed 441 for, 105 against, 81 abstainedPosition: For Majority line: For
10 Mar 2026European Union regulatory fitness and subsidiarity and proportionality – report on Better Law-Making covering 2023 and 2024 Adopted 493 for, 92 against, 44 abstainedPosition: For Majority line: For
10 Mar 2026Housing crisis in the European Union with the aim of proposing solutions for decent, sustainable and affordable housing Adopted 367 for, 166 against, 84 abstainedPosition: Abstained ≠ groupMajority line: For
10 Mar 2026Public access to documents - report 2022 - 2024 Adopted 602 for, 9 against, 8 abstainedPosition: For Majority line: For
10 Mar 2026Copyright and generative artificial intelligence – opportunities and challenges Adopted 460 for, 71 against, 88 abstainedPosition: For Majority line: For
10 Mar 2026Fisheries management approaches for safeguarding sensitive species, tackling invasive species and benefiting local economies Adopted 528 for, 21 against, 62 abstainedPosition: For Majority line: For
10 Mar 2026The upcoming European Research Area (ERA) Act Adopted 399 for, 78 against, 69 abstainedPosition: For Majority line: For
24 Feb 2026Four years of Russia’s war of aggression against Ukraine and European contributions to a just peace and sustained security for Ukraine Adopted 437 for, 82 against, 70 abstainedPosition: For Majority line: For
12 Feb 2026Cooperation among enforcement authorities regarding unfair trading practices in the agri-food supply chain Passed 555 for, 0 against, 26 abstainedPosition: For Majority line: For
12 Feb 2026Post-election situation in Uganda and threats against opposition leader Bobi Wine Adopted 514 for, 3 against, 56 abstainedPosition: For Majority line: For
12 Feb 2026Systemic oppression, inhumane conditions and arbitrary detentions by the regime in Iran Adopted 524 for, 3 against, 41 abstainedPosition: For Majority line: For
12 Feb 2026Targeted expulsions of foreign journalists and foreign Christians in Türkiye under national security pretexts Adopted 502 for, 2 against, 59 abstainedPosition: For Majority line: For
12 Feb 2026Developing a new EU anti-poverty strategy Adopted 385 for, 141 against, 53 abstainedPosition: For Majority line: For
12 Feb 2026Addressing subcontracting chains and the role of intermediaries in order to protect workers’ rights Adopted 332 for, 209 against, 33 abstainedPosition: For Majority line: For
12 Feb 2026Recommendation to the Council on EU priorities for the 70th session of the UN Commission on the Status of Women Adopted 340 for, 141 against, 68 abstainedPosition: For Majority line: For
12 Feb 2026Situation in Northeast Syria, the violence against civilians and the need to maintain a sustainable ceasefire Adopted 363 for, 71 against, 81 abstainedPosition: For Majority line: For
11 Feb 2026Regulation implementing enhanced cooperation on the establishment of the Ukraine Support Loan for 2026 and 2027 Passed 458 for, 140 against, 44 abstainedPosition: For Majority line: For
11 Feb 2026Amending Regulation (EU) 2024/792 establishing the Ukraine Facility Passed 473 for, 140 against, 32 abstainedPosition: For Majority line: For
11 Feb 2026Amending the multiannual financial framework for the years 2021 to 2027 Consent given 490 for, 130 against, 32 abstainedPosition: For Majority line: For
11 Feb 2026Mobilisation of the European Globalisation Adjustment Fund: application EGF/2025/006 BE/Audi – Belgium Passed 593 for, 55 against, 9 abstainedPosition: For Majority line: For
11 Feb 2026Genetically modified soybean DBN-09004-6 Objection passed 461 for, 169 against, 22 abstainedPosition: For Majority line: For
11 Feb 2026Genetically modified maize T25 (ACS-ZMØØ3-2) Objection passed 462 for, 169 against, 22 abstainedPosition: For Majority line: For
11 Feb 2026Genetically modified cotton T304-40 Objection passed 428 for, 156 against, 22 abstainedPosition: For Majority line: For
11 Feb 2026Genetically modified cotton GHB614 × LLCotton25 Objection passed 463 for, 164 against, 21 abstainedPosition: For Majority line: For
11 Feb 2026Interim report in view of the consent procedure on the Agreement establishing an association between the EU and the Principality of Andorra and the Republic of San Marino Interim report adopted 552 for, 24 against, 75 abstainedPosition: For Majority line: For
11 Feb 2026EU strategic defence and security partnerships Adopted 440 for, 119 against, 85 abstainedPosition: For Majority line: For
10 Feb 2026Establishment of a list of safe countries of origin at Union level Passed 408 for, 184 against, 60 abstainedPosition: Against Majority line: Against
10 Feb 2026Application of the ‘safe third country’ concept Passed 396 for, 226 against, 30 abstainedPosition: Against Majority line: Against
10 Feb 2026Amending regulations on agricultural products as regards market rules and sectoral support measures in the wine sector and for aromatised wine products Passed 625 for, 15 against, 11 abstainedPosition: For Majority line: For
10 Feb 2026Amending the Measuring Instruments Directive Passed 594 for, 25 against, 23 abstainedPosition: For Majority line: For
10 Feb 2026Bilateral safeguard clause of the EU-Mercosur Partnership Agreement and the EU-Mercosur Interim Trade Agreement for agricultural products Passed 483 for, 102 against, 67 abstainedPosition: Abstained ≠ groupMajority line: For
10 Feb 2026Framework for achieving climate neutrality Passed 413 for, 226 against, 12 abstainedPosition: For Majority line: For
10 Feb 2026European Union designs (codification) Passed 613 for, 5 against, 29 abstainedPosition: For Majority line: For
10 Feb 2026European Central Bank – annual report 2025 Adopted 443 for, 71 against, 117 abstainedPosition: For Majority line: For
22 Jan 2026Motion of censure on the Commission Rejected 165 for, 390 against, 10 abstainedPosition: Against Majority line: Against
22 Jan 2026Conviction and imminent sentencing of Jimmy Lai in Hong Kong Adopted 503 for, 9 against, 100 abstainedPosition: For Majority line: For
22 Jan 2026Case of Joseph Figueira Martin in the Central African Republic Adopted 582 for, 0 against, 35 abstainedPosition: For Majority line: For
22 Jan 2026Drones and new systems of warfare – the EU’s need to adapt to be fit for today’s security challenges Adopted 483 for, 68 against, 76 abstainedPosition: For Majority line: For
22 Jan 2026Choice of performance indicators for audit and budgetary control in the context of financing measures to support the implementation of future European competitiveness Adopted 318 for, 247 against, 67 abstainedPosition: Against Majority line: Against
22 Jan 2026European technological sovereignty and digital infrastructure Adopted 471 for, 68 against, 71 abstainedPosition: No vote recorded Majority line: For
22 Jan 2026Brutal repression against protesters in Iran Adopted 562 for, 9 against, 57 abstainedPosition: For Majority line: For
22 Jan 2026Attempted takeover of Lithuania’s public broadcaster and the threat to democracy in Lithuania Adopted 385 for, 165 against, 35 abstainedPosition: For Majority line: For
21 Jan 2026Air passenger rights Amendments 1 + 243 (voted as one) adopted 632 for, 15 against, 9 abstainedPosition: For Majority line: For
21 Jan 2026EU-Bosnia and Herzegovina Agreement on operational activities carried out by the European Border and Coast Guard Agency in Bosnia and Herzegovina Consent given 565 for, 83 against, 14 abstainedPosition: For Majority line: For
21 Jan 2026Enhanced cooperation on the establishment of a Loan for Ukraine Consent given 499 for, 135 against, 24 abstainedPosition: For Majority line: For

Show all 50 votes on this page

Roll-call participation

One cell per sitting while in office, shaded by the share of that day’s roll calls the member voted in. The official attendance register is kept separately by Parliament.

No vote recorded on 14 of 80 sittings with roll calls.

"No vote recorded" is not the same as absent: leave, illness and chairing the sitting look the same.

Data as a table

Voting neighbours

Members who voted the same way most often in the roll calls they both took part in, within and outside the member’s group (group at the date of each vote), over all roll calls of the term.

At least 200 shared roll calls over at least six months in office together. Within = both sat in the same group on the date of the vote; a member who changed group can appear on both lists. Baseline = the median agreement of all pairs of members of the groups the two sat in on the date of each shared vote (within: the group they shared; outside: the two groups), weighted by the votes they shared in each combination.

Within S&D

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in the same group (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of that group.
SelectMemberGroupCountryAgreementBaseline
Raphaël GLUCKSMANN S&DFrance99 % of 4 557 shared93 %
Emma RAFOWICZ S&DFrance99 % of 3 523 shared93 %
Aurore LALUCQ S&DFrance99 % of 4 157 shared93 %
Murielle LAURENT S&DFrance99 % of 4 699 shared93 %
Thomas PELLERIN-CARLIN S&DFrance99 % of 4 943 shared93 %
Eric SARGIACOMO S&DFrance98 % of 4 762 shared93 %
Nora MEBAREK S&DFrance98 % of 4 612 shared93 %
Pierre JOUVET S&DFrance98 % of 4 406 shared93 %
Claire FITA S&DFrance98 % of 4 062 shared93 %
Chloé RIDEL S&DFrance98 % of 3 432 shared93 %

Outside the group

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in different groups (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of the groups the two sat in on those votes (groups at the date, weighted by the votes shared in each combination).
SelectMemberGroupCountryAgreementBaseline
Catarina VIEIRA GreensNetherlands87 % of 4 580 shared83 %
Kim VAN SPARRENTAK GreensNetherlands87 % of 4 724 shared83 %
Bas EICKHOUT Former memberGreensNetherlands87 % of 3 978 shared83 %
Terry REINTKE GreensGermany87 % of 4 639 shared83 %
Sara MATTHIEU GreensBelgium87 % of 4 411 shared83 %
Tineke STRIK GreensNetherlands87 % of 4 770 shared83 %
Jana TOOM RenewEstonia87 % of 4 355 shared86 %
Yvan VEROUGSTRAETE RenewBelgium86 % of 3 864 shared86 %
Maria OHISALO GreensFinland86 % of 4 418 shared83 %
Erik MARQUARDT GreensGermany86 % of 4 784 shared83 %

Work

Seats in committees, delegations and intergroups, and the dossiers the member leads, shadows or negotiates.

Seats

Body: the committee, delegation or intergroup, with its kind. Role: the member’s role in it. From, To: the dates of the seat (“now” while it lasts).
BodyRoleFromTo
Committee on DevelopmentDEVE CommitteeSubstitute19 Jul 2024now
Committee on the Environment, Climate and Food SafetyENVI CommitteeMember20 Jan 2025now
Committee on Industry, Research and EnergyITRE CommitteeSubstitute19 Jul 2024now
Committee on Public HealthSANT CommitteeMember23 Jan 2025now
Delegation to the OACPS-EU Joint Parliamentary AssemblyDACP Parliamentary assemblyVice-chair3 Oct 2024now
Delegation to the Africa-EU Parliamentary AssemblyDAFR Parliamentary assemblyVice-chair30 Sept 2024now
Intergroup on Attracting Investment to Ensure a Competitive and Sustainable European UnionIG10-03 Intergroup / working groupMember31 Jan 2025now
Intergroup on Cancer and Rare DiseasesIG10-05 Intergroup / working groupMember27 Jan 2025now
Intergroup on Fighting against PovertyIG10-12 Intergroup / working groupMember20 Feb 2026now
Intergroup on the Future of Education and Skills for a Competitive EuropeIG10-14 Intergroup / working groupMember29 Jan 2025now

Show all 20 seats

Dossiers

Dossier: the procedure the declaration names (“No dossier named” for a delegation without one). Role: rapporteur, shadow rapporteur, negotiator or delegation. Committee: the committee that appointed them. Date: of the declaration.
DossierRoleCommitteeDate
Establishing a framework of measures for the acceleration of industrial capacity and decarbonisation in strategic sectors and amending Regulations (EU) 2018/1724, (EU) 2024/1735 and (EU) 2024/3110Shadow rapporteur for an opinionENVI18 Jun 2026
AACP delegation in Abidjan (May 2026)Official delegationDAFR10 Mar 2026
European Chemicals Agency and amending Regulations (EC) No 1907/2006, (EU) No 528/2012, (EU) No 649/2012 and (EU) 2019/1021RapporteurENVI8 Dec 2025
Gender inequalities in health, specifically as regards gender-specific conditionsShadow rapporteur for an opinionSANT13 Nov 2025
Union Civil Protection Mechanism and Union support for health emergency preparedness and response, and repealing Decision No 1313/2013/EU (Union Civil Protection Mechanism)Shadow rapporteurSANT13 Nov 2025
Union Civil Protection Mechanism and Union support for health emergency preparedness and response, and repealing Decision No 1313/2013/EU (Union Civil Protection Mechanism)Shadow rapporteurSANT29 Oct 2025
Ensuring faster registration and uptake of biological control agentsShadow rapporteurENVI8 Jul 2025
No dossier namedOfficial delegationENVI13 May 2025
the Plants obtained by certain new genomic techniques and their food and feed, and amending Regulation (EU) 2017/625Shadow rapporteurENVI25 Nov 2024
No dossier namedOpinion rapporteur · 2 declarationsENVI25 Nov 2024

Show all 14 dossier roles

Topics they work on (model-assigned)

Counts: dossiers they spoke on, led or amended, and their questions and motions.

In the chamber

Speeches and statements in plenary debates, newest first; the verbatim report is on Parliament’s site.

48 contributions recorded; 15 on behalf of their group; 61 minutes of speaking time.

Show all 40 recent contributions

Questions and motions, 54

Parliamentary questions and motions for resolutions the member authored or co-signed, newest first.

Date: tabled. Title: the question or motion, with its id. Kind: written question or motion for a resolution, with the number of co-authors. Answer: the date of the answer to a question.
DateTitleKindAnswer
11 Sept 2026MOTION FOR A RESOLUTION on the draft Commission regulation amending Annex II to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for azoxystrobin, etofenprox, fenpropidin, flupyradifurone, hexythiazox, imazalil, spinosad and tebufenozide in or on certain products B-10-2026-0392Motion for a resolutionwith 3 co-authors—
10 Sept 2026EU exports of banned pesticides E-10-2026-003605Written questionwith 35 co-authorsNot yet answered
14 Jul 2026Preserving EU capacities to produce paper pulp and cellulose fibres – state of affairs at Fibre Excellence P-10-2026-002901Priority written questionwith 12 co-authors12 Aug 2026
8 Jul 2026European funds allocated to fighting period poverty E-10-2026-002822Written questionwith 36 co-authorsNot yet answered
3 Jul 2026Follow-up to the European Citizens’ Panel on Preparedness E-10-2026-002778Written questionwith 9 co-authors21 Aug 2026
1 Jul 2026PROPOSAL FOR A DECISION requesting the Authority for European Political Parties and European Political Foundations to verify whether Europe of Sovereign Nations Party complies with the conditions laid down in Article 3(1), points (d) and (e), of Regulation (EU, Euratom) 2025/2445 B-10-2026-0338Motion for a resolutionwith 246 co-authors—
30 Jun 2026Follow-up to question for written answer E-001083/2025 on menstrual products: transparency and health risks E-10-2026-002698Written questionwith 43 co-authors18 Sept 2026
29 Jun 2026Allowing advanced practice nurses to renew or adapt treatments E-10-2026-002671Written question21 Aug 2026
19 Jun 2026Ban the butt: it is time to stub out cigarette filters E-10-2026-002547Written questionwith 9 co-authors3 Sept 2026
23 Apr 2026Risks hanging over the European steel industry and use of public funding by ArcelorMittal E-10-2026-001682Written questionwith 12 co-authors8 Jun 2026

Show all 54 questions and motions

Amendments tabled in committee, 95

Committee amendment documents that carry amendments by the member, with how many are theirs.

Date: of the amendment document. Text amended: the dossier and the document’s id. Committee: where the amendments were tabled. Amendments: how many in the document are the member’s.
DateText amendedCommitteeAmendments
10 Sept 2026Amending Directives 2001/18/EC and 2010/53/EU as regards the placing on the market of genetically modified micro-organisms and the processing of organs CJ64-AM-792138 CJ6422
10 Sept 2026Amending Directives 2001/18/EC and 2010/53/EU as regards the placing on the market of genetically modified micro-organisms and the processing of organs CJ64-AM-792139 CJ6432
23 Jul 2026Proposal for a Regulation of the European Parliament and of the Council establishing a framework of measures for the acceleration of industrial capacity and decarbonisation in strategic sectors and amending Regulations (EU) 2018/1724, (EU) 2024/1735 and (EU) 2024/3110 ENVI-AM-791125 ENVI71
23 Jul 2026Proposal for a Regulation of the European Parliament and of the Council establishing a framework of measures for the acceleration of industrial capacity and decarbonisation in strategic sectors and amending Regulations (EU) 2018/1724, (EU) 2024/1735 and (EU) 2024/3110 ENVI-AM-791124 ENVI50
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790005 CJ533
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790936 CJ533
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790934 CJ531
23 Jun 2026on the proposal for a regulation of the European Parliament and of the Council establishing the European Fund for economic, social and territorial cohesion, agriculture and rural, fisheries and maritime, prosperity and security for the period 2028-2034 and amending Regulation (EU) 2023/955 and Regulation (EU, Euratom) 2024/2509 CJ71-AM-790094 CJ712
23 Jun 2026on the proposal for a regulation of the European Parliament and of the Council establishing the European Fund for economic, social and territorial cohesion, agriculture and rural, fisheries and maritime, prosperity and security for the period 2028-2034 and amending Regulation (EU) 2023/955 and Regulation (EU, Euratom) 2024/2509 CJ71-AM-790103 CJ712
23 Jun 2026on the proposal for a regulation of the European Parliament and of the Council establishing the European Fund for economic, social and territorial cohesion, agriculture and rural, fisheries and maritime, prosperity and security for the period 2028-2034 and amending Regulation (EU) 2023/955 and Regulation (EU, Euratom) 2024/2509 CJ71-AM-790092 CJ711

Show all 95 amendment documents

Connections

Dossiers they lead or shadow, committees, party, delegation and other related pages.

Political group

National delegation

  • Delegation France National delegation

Sources & citation

Where the facts on this page come from, and how to cite it.

Data source
Licensed CC BY 4.0.
Data version
data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1 · methods
Retrieved
25 September 2026

Cite as

EU Parl Watch Research (2026). “Christophe CLERGEAU”. Member record. memberId 245018. EU Parl Watch Research. https://news.eu-parl.st-solutions.dev/members/245018?nb=all&page=5&scope=final (retrieved 25 September 2026). Official source: Member’s profile, European Parliament, https://www.europarl.europa.eu/meps/en/245018. Data: EP Open Data: member record, https://data.europarl.europa.eu/api/v2/meps/245018?format=application%2Fld%2Bjson (CC BY 4.0); data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1.
BibTeX
@misc{epw-member-245018,
  author = {{EU Parl Watch Research}},
  title = {{Christophe CLERGEAU}},
  year = {2026},
  howpublished = {\url{https://news.eu-parl.st-solutions.dev/members/245018?nb=all&page=5&scope=final}},
  url = {https://news.eu-parl.st-solutions.dev/members/245018?nb=all&page=5&scope=final},
  urldate = {2026-09-25},
  publisher = {EU Parl Watch Research},
  note = {Member record. memberId 245018. Official source: https://www.europarl.europa.eu/meps/en/245018. Data: EP Open Data: member record (CC BY 4.0); data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1}
}